Description

Settlement calendar for the takeover offer to buy acquisition window for J.B. Chemicals & Pharmaceuticals Limited, to be conducted from November 18, 2025 to December 1, 2025.

Summary

BSE has announced the settlement schedule for the Offer to Buy – Acquisition Window (Takeover) for J.B. Chemicals & Pharmaceuticals Limited. The takeover bidding window will be open from November 18, 2025 to December 1, 2025, with settlement number 2025121. Obligation download is scheduled for December 12, 2025, and final settlement on December 15, 2025.

Key Points

  • Settlement Type: Takeover (Settlement No. 2025121)
  • Bid Period: November 18, 2025 to December 1, 2025
  • Demat shares must be delivered only through Early Pay-in of Shares mechanism available in both depositories
  • Market Type “(Takeover)” and settlement number 2025121 must be used by Members/Custodians in the depository system
  • CDSL & NSDL early pay-in securities will be earmarked/blocked in clients’ accounts with requisite market type and settlement number
  • Members are NOT required to upload any EPN file
  • Members should refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise Stamp Duty charges

Regulatory Changes

Members and Custodians must follow the Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange as per Notice No.20200528-32 dated May 28, 2020.

Compliance Requirements

  • Participants must ensure early pay-in of securities is reflected in BSE/ICCL systems before prescribed timelines for accepting/confirmation of Bids by the BSE OTB platform
  • Complete the process of early pay-in of securities in the Depository system sufficiently in advance before prescribed timelines for:
    • Closure of BSE OTB Bidding window for placing bids by members
    • Confirmation window for confirming Bids by Custodians
  • Use Market Type “(Takeover)” and settlement number 2025121 in all depository transactions
  • Refer to relationship managers or ICCL Help Desk for clarifications (Contact: 022-69158590/45720490/45720690, Email: iccl.helpdesk@icclindia.com)

Important Dates

  • Bid Start Date: November 18, 2025
  • Bid End Date: December 1, 2025
  • Obligation Download: December 12, 2025
  • Settlement Date: December 15, 2025

Impact Assessment

This takeover offer will impact shareholders of J.B. Chemicals & Pharmaceuticals Limited who wish to participate in the acquisition window. Members and Custodians must ensure compliance with early pay-in requirements and prescribed timelines to facilitate smooth settlement. The settlement process follows established guidelines for acquisition of shares through stock exchange, ensuring transparency and orderly conduct of the takeover offer.

Impact Justification

Corporate action involving takeover offer requiring specific settlement procedures and timelines for shareholders and members participating in the acquisition window